Ventis Pharma

Enhancing health and comfort through innovative
pain management

We provide physicians and surgeons with better pain relief solutions for their patients. We aim to improve Post-Operative Care with safer, more effective, and more
Accessible Pain Management Formulations.

Safer solution that enhances postoperative care

Ventis Pharma, led by a team of medical experts encompassing a surgeon, an anesthesiologist, and a nurse anesthetist, is dedicated to enhancing postoperative care. Our breakthrough product, Enduracaine™, is a safe, long-lasting, and opioid-free local anesthetic that redefines pain relief for patients. With a focus on nerve blocks, compartment blocks, and wound infiltration, our innovative solutions cater to various surgical procedures. Join us in revolutionizing postoperative pain management and improving patient recovery.

Enduracaine™ revolutionizing postoperative pain management

Ventis Pharma introduces a groundbreaking solution designed for hospital boards seeking to improve postoperative care. Our revolutionary product, Enduracaine™, stands as a highly effective alternative to existing post-operative local anesthetics that have faced challenges in gaining widespread adoption. High toxicity, inefficacy, and exorbitant costs have hindered the success of current options.
Enduracaine™, Ventis Pharma’s new formulation, is currently undergoing US FDA IND tests and studies, paving the way for subsequent FDA clinical trials. This rigorous testing process is set to substantiate the product’s safety, efficiency, and effectiveness. Notably, Enduracaine™ combines existing, approved USP products, ensuring its use is safe and acceptable even prior to specific FDA approval through a New Drug Application.
Initial off-label trials, encompassing over 2500 patients, have yielded remarkable results. These trials have demonstrated substantial and enduring reductions in postoperative pain, coupled with a notable decrease in the necessity for additional medications, including opioids. The product has been met with remarkable acceptance by both patients and clinicians, with minimal adverse effects observed.
Enduracaine™ emerges as a groundbreaking pain relief solution suitable for a diverse array of surgical procedures. This innovation holds the promise of transforming postoperative care, aligning with hospital boards’ commitment to excellence and patient well-being.

Global Presence

Ventis Pharma has received patents, and has patents pending, in more than 40 countries. With the help of Enduracaine™, we can provide superior analgesic solutions to patients undergoing more than 350 million surgeries a year.

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

LONG-LASTING

Paradigm shift in
regional anesthesia

SAFE

COST-EFFECTIVE

Latest news

Stay Informed with the Latest Innovations and News from Ventis Pharma

Trusted partner

As the developer of certain patented formulations, Ventis Pharma has provided Nubratori RX the license to manufacture the Endura-KT formulation under its FDA 503B Outsourcing facility. Nubratori RX is a licensed FDA 503B Outsourcing Facility where all products are manufactured in the USA according to FDA CGMP regulations

Enhancing health and comfort through innovative
pain management

We provide physicians and surgeons with better pain relief solutions for their patients. We aim to improve Post-Operative Care with safer, more effective, and more
Accessible Pain Management Formulations.